Syon Capital’s Revolution Medicines RVMD Stock Holding History

Syon Capital’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7,306	Closed	-$320K	–	652
2024 Q4	$320K	Buy	+7,306	New	+$369K	0.03%	380

Other funds holding RVMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Syon Capital's RVMD Position: Q1 2025 in Review

Syon Capital sold out of Revolution Medicines (RVMD) in Q1 2025, closing a stake of 7,306 shares — an estimated $320K sold.

Syon Capital first reported a position in RVMD in Q4 2024 and held it in 1 quarter. The position peaked at $320K in Q4 2024. 284 funds tracked by Wall St. Rank hold RVMD as of Q1 2025.

Syon Capital reported no remaining Revolution Medicines position as of Q1 2025 after selling out during the quarter.
Syon Capital sold 7,306 Revolution Medicines shares in Q1 2025, an estimated $320K.
Syon Capital first reported a position in Revolution Medicines in Q4 2024 and held it in 1 quarter.
Syon Capital's Revolution Medicines position peaked at $320K in Q4 2024.
284 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2025.

Based on Syon Capital's 13F filing for Q1 2025, filed 15 May 2025.